Navigation Links
Osteotech Announces Preliminary Fourth Quarter 2009 Revenue
Date:1/14/2010

EATONTOWN, N.J., Jan. 14 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, today reported preliminary unaudited revenue for the fourth quarter of 2009 of $26.3 million compared with $24.6 million for the same period in 2008.  During the fourth quarter, the Company generated $1.0 million in revenue from sales of its new innovative products all currently in limited launch phases.  Revenue in the fourth quarter of 2009 also included $3.3 million in revenue from an agreement to license certain of the Company's tissue processing technology, which, net of related expenses, is expected to contribute approximately $2.3 million to fourth quarter profitability.  The Company realized all of the revenue under the arrangement in the fourth quarter of 2009 and will receive the consideration over the next 3.5 years.  Based upon the preliminary unaudited fourth quarter results, the Company expects to report approximately $96.7 million in revenue for full year 2009.  Excluding the one-time impact on revenue of the new licensing arrangement, the Company expects to report full year 2009 revenue of $93.4 million.  The Company previously provided revenue guidance for 2009 of between $92 and $94 million.  

Osteotech also reported that it exited 2009 with approximately $10.7 million in cash.  The Company's guidance for its cash position was between $9 and $10 million.
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting
2. Osteotech Reports Third Quarter 2009 Financial Results
3. Osteotechs MagniFuse(TM) Technology Used in First U.S. Surgery
4. Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
5. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
6. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
7. Elbit Imaging Announces InSightecs First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
8. Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
9. The Foundry Announces Completion of Series A Financing for Twelfth Company
10. DATATRAK International, Inc. Announces Year-End Backlog
11. Stryker Corporation Announces Pricing of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... all-time hits leader, is the new spokesperson for the topical ... announced. "Pete,s a Hall of Famer in our ... with Myoflex," said Ducere Pharma Chief Executive Officer Chris ... across all generations. The passion and intensity that Pete brought ...
(Date:1/23/2015)... VEGAS , Jan. 23, 2015 Cord Blood America, ... ) ("CBAI" or the "Company")  filed a Preliminary Proxy Statement, ... www.sec.gov ) today, and provides an update for shareholders detailing ... shares is requested. Dear Shareholders, As ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... and development company, is delighted to announce that the ... to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for the ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Four years since the ... – which coincided with the marriage of Avasa & Matthew Love ... ROAD, which is scheduled for release through White Swan Records on ... that there is a sacred path available to all of us ...
(Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... published research in the April 9 issue of Archives ... cocoa are beneficial// in reducing blood pressure, instead of ... guidelines advise individuals with hypertension (high blood pressure) to ... in the article. Compounds known as polyphenols or flavonoids ...
... has another new risk- it heightens your chances of developing ... in fact set you on the road to Alzheimer’s. ... of Archives of Neurology, one of the JAMA/Archives journals. ... been consistently related to a higher risk of Alzheimer's disease," ...
... Novartis case, the government of India is moving fast to ... has now been notified that all patent litigations filed in ... Patent Act have been transferred to the Intellectual Property Appellate ... companies have filed cases in High Courts and lower courts ...
... to data released by Banfield, The Pet Hospital, one of ... 39,000 cats and dogs// were sickened or killed nationwide consequent ... ,The data was reportedly compiled from records collected from more ... massive recall of contaminated pet food. Described as one of ...
... (TYC) facilities continue to reel under allegations of ward neglect ... about the agency. , Leaders of the state ... juvenile inmates, as well as gross neglect of their health. ... had to wait up to even months before they were ...
... of hepatitis B patients, said an official of the ... 500,000 people die of liver damage and hepatocirrhosis triggered ... ,He said about 120 million Chinese test ... health problem in the country. ,HPF and ...
Cached Medicine News:Health News:Blood Pressure Tackled Better With Cocoa Than Tea 2Health News:Diabetes May Bring You A Step Closer To Alzheimer’s Diseas 2Health News:Patents: Appellate Board Becomes Functional 2Health News:Melamine Contamination Killed Thousands of Pets, Says a New Report 2
Clearview RSV is a simple, immunochromatographic assay to aid in the diagnosis of respiratory syncytial virus (RSV) infections in children less than 6 years and adults over age 60....
... one of the easiest tests to run on ... 15 minutes with no hands-on time. Critical care ... the child leaving the pediatrician's office and valuable ... to help control the spread of RSV infections. ...
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. Make ...
Medicine Products: